-
Innovation Ranking
Innovation Ranking – BGI Genomics Co Ltd
BGI Genomics Co Ltd (BGI Genomics), a subsidiary of Beijing BGI-GBI Biotech Co Ltd BGI, provides next generation sequencing services and genetic tests. The company offers services including DNA (deoxyribonucleic acid) sequencing, RNA (ribonucleic acid) sequencing, non-invasive prenatal testing, newborn genetic screening, reproductive health screening, customized sequencing services and clinical exome sequencing services. BGI Genomics also conducts research to advance precision medicine and diagnostics in the fields of metagenomics, reproductive health and for detecting cancer. It serves various medical institutions,...
-
Product Insights
NewMGI Tech Co Ltd Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our MGI Tech Co Ltd Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. MGI Tech Co Ltd (MGI Tech), a subsidiary of BGI Genomics Co Ltd, is a genomics company. It focuses on research, development, manufacturing and sales of DNA sequencing instruments and reagents. The company offers sequencers for whole genome sequencing, deep exome sequencing, transcriptome sequencing, targeted DNA, epigenetics and clinical applications. It also provides automated sample preparation systems and...
-
Company Insights
Innovation and Patenting activity of BGI Genomics Co Ltd Q1 2024
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of BGI Genomics Co Ltd Q1 2024". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will...
-
Sector Analysis
Prenatal Screening Market Size by Segments, Share, Regulatory, Reimbursement and Forecast to 2033
Prenatal Screening Market Report Overview The prenatal screening market size was $669.3 million in 2023 and will grow at a CAGR of more than 1% from 2023 to 2033. Pre-natal screening describes tests that detect potential problems that affect the viability and development of the fetus using both less invasive and more invasive sampling techniques. Prenatal Screening Market Outlook 2023-2033 ($ Million) Buy the Full Report for More Insights into the Prenatal Screening Market Forecast, Download a Free Sample Report...
-
Sector Analysis
COVID-19 Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033
COVID-19 tests Market Report Overview The COVID-19 tests market size was valued at $23.97 billion in 2023. The market will decline at a CAGR of more than 22%. COVID-19 tests are used to screen for and identify infections caused by the SARS-CoV-2- coronavirus, an emerging pathogen that was first discovered in China in the early 21st century. The COVID-19 test can be performed using point-of-care rapid testing, laboratory-based ELISA testing, or PCR. COVID-19 Tests Market Outlook 2023-2033 ($ Billion) Buy...
-
Sector Analysis
BRAF Tests Market Size by Segments, Share, Regulatory, Reimbursement and Forecast to 2033
BRAF Tests Market Report Overview The BRAF tests market size was valued at $14.2 million in 2023. Factors including increasing incidence of melanoma and colorectal and lung cancers will drive the BRAF tests market to grow at a CAGR of more than 6% during 2023-2033. Mutation testing from formalin-fixed paraffin-embedded tumor tissue is standard practice for metastatic melanoma and can be performed on multiple sample types including resected specimens, biopsies, and needle biopsies. The most important factors to ensure quality...
-
Product Insights
Colorectal Cancer Screening Tests Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Colorectal Cancer Screening Tests Pipeline Market Report Overview The colorectal cancer screening Tests pipeline market research report provides comprehensive information about the colorectal cancer screening tests pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials that are in progress. Key Segments ·       Other Colorectal Cancer Screening Tests ·       Fecal DNA Test Kits ·       Immunochemical Fecal Occult Blood Test (iFOBT or FIT) Kits Key Territories ·       The US ·       Europe...
-
Company Insights
NewTop Biotechnology Foreign Direct Investment Companies
Top Biotechnology Foreign Direct Investment Companies report analyzes the most active greenfield FDI investors globally (based on number of projects) in the Biotechnology sector between Q1 2019 and Q1 2024. Additionally, the report highlights where these top Biotechnology investors are investing in what type of operations. The report also provides an overview of notable FDI projects from these top investors. The report will be delivered within 2-3 business days of the purchase, excluding weekends and holidays. Certain sections of the...
-
Thematic Analysis
Synthetic Biology – Thematic Intelligence
Synthetic Biology Thematic Report Overview Synthetic biology is commonly abbreviated to synbio. It involves the manipulation of genetic material to enhance specific characteristics or, conversely, stifle them. The ability to perform this manipulation quickly, precisely, and at a low cost has the potential to impact numerous sectors. From developing environmentally friendly luxury materials to novel cancer therapeutics and even the use of DNA as a new form of data storage, the forthcoming field of synbio unlocks several new realms of...